Yankees Score with ...
Health Care: Drugs
Theravance Inc. (THRX: NASDAQ)
$36.24 -0.54 | -1.47%
05/24/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with THRX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ProSeth Klarman - Baupost Group
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Usernew
Latest THRX Headlines from TheStreet
- 3 Stocks Pushing The Drugs Industry Higher 04.15.13 | 01:04 pm
- 5 Stocks Poised to Pop on Bullish Earnings 02.11.13 | 12:02 pm
- Insiders Trading THRX KSS TUES ELGX 11.06.12 | 10:11 am
- Theravance And Merck Sign Cardiovascular Disease Collaboration 10.16.12 | 08:10 am
- Theravance And Alfa Wassermann Enter Into Agreement To Develop And Commercialize Velusetrag For Gastroparesis 10.02.12 | 04:10 pm
- GSK And Theravance Announce FDA Acceptance Of FF/VI New Drug Application (NDA) Submission In The US For COPD 09.26.12 | 04:09 am
- Theravance's Management Presents At INC At Morgan Stanley Healthcare Conference (Transcript) 09.12.12 | 02:09 pm
- Theravance To Present At The Morgan Stanley Global Healthcare Conference 08.29.12 | 04:08 pm
- GSK And Theravance Announce Completion Of The Phase III Programme For Once-Daily LAMA/LABA (UMEC/VI) In COPD 08.24.12 | 07:08 am
- Theravance Inc. Stock Downgraded (THRX) 08.02.12 | 05:08 am
Press Releases for THRX
- BREOâ¿¢ ELLIPTAâ¿¢ Gains US Approval For The Treatment Of COPD - PR Newswire 05.10.13 | 04:05 pm
- FDA Advisory Committee Recommends Approval Of BREOâ¿¢ ELLIPTAâ¿¢ For The Treatment Of COPD - PR Newswire 04.17.13 | 05:04 pm
Partner Headlines for THRX
- Elan steps up fight against Royalty Pharma bid - Financial Times 05.20.13 | 05:05 pm
- Theravance, Glaxo, Elan Star In Biotech Soap Opera - Investor's Business Daily 05.13.13 | 05:05 pm
- Glaxo, Theravance Confirm BREO ELLIPTA Gained US FDA Approval for Treatment of COPD - Benzinga 05.10.13 | 12:05 pm
- Theravance Earnings: Here’s Why Investors Don’t Like These Results - Wall St. Cheat Sheet 04.25.13 | 08:04 am
- Morning Market Movers - Benzinga 04.15.13 | 09:04 am
- Pipeline Progress at Theravance - Analyst Blog - Zacks 12.05.12 | 09:12 am
- Glaxo Invests in Nigeria - Analyst Blog - Zacks 11.28.12 | 09:11 am
- For NovaBay, Simplicity Is The Father Of Invention - Seeking Alpha 11.12.12 | 09:11 am
- Loss at THRX Narrower Than Expected - Analyst Blog - Zacks 10.31.12 | 09:10 am
- Glaxo Aims to Expand Synflorix Label - Analyst Blog - NASDAQ 09.19.12 | 03:09 pm
